Presentation is loading. Please wait.

Presentation is loading. Please wait.

Antibiotic Therapy in the Critically Ill Surgical and Trauma Patient - Monobactams Carbapenems, Quinolones Nir Hus MD., PhD. 01/12/2011.

Published byAnthony King Modified over 11 years ago

Similar presentations

Presentation on theme: "Antibiotic Therapy in the Critically Ill Surgical and Trauma Patient - Monobactams Carbapenems, Quinolones Nir Hus MD., PhD. 01/12/2011."— Presentation transcript:

1 Antibiotic Therapy in the Critically Ill Surgical and Trauma Patient - Monobactams Carbapenems, Quinolones Nir Hus MD., PhD. 01/12/2011

2 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

3 CARBAPENEMS Imipenem/Cilastatin (Primaxin) Meropenem
Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

4 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
CARBAPENEMS β-lactams that contain a fused β-lactam ring and a 5- membered ring system that differs from the penicillins in being unsaturated (double bond between C-2 and C-3) and containing a carbon atom instead of the sulfar atom. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

5 Imipenem / Cilastatin, i.v
Mechanism of action Imipenem like other β-lactam antibiotics binds to penicillin- binding proteins, disrupts bacterial cell wall synthesis and cause death of susceptible micro-organisms. Antibacterial spectrum Aerobic & anaerobic G+ (S. aureus, Enterococci and Streptococci) & G- including pseudomonas and most enterobacter. MRSA is less susceptible Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

6 Imipenem / Cilastatin, i.v
Pharmacokinetics Not absorbed orally ( i.v infusion ) Poor distribution in CSF (not used in meningitis) Partly broken down by dehydropeptidase in the proximal tubule- given with cilastatin ( dihydropeptidase inhibitor ) Excreted primarily by the kidney Doses must be reduced in renal failure Half- life about 1 hr Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

7 Imipenem / Cilastatin, i.v
Clinical uses: Infections require multiple antibiotics ( useful in nosocomial infections ) Not used alone for resistant pseudomonas infections Not used for MRSA infections Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

8 Imipenem / Cilastatin, i.v
Side effects Similar to those seen with B- lactams Nausea & vomiting are frequent Excessive levels with renal failure may lead to seizures Pts allergic to penicillins may be allergic to imipenem Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

9 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
MEROPENEM Meropenem is a second generation carbapenem. Meropenem is not hydrolyzed by DHP-I and is resistant to most β-lactamases, including a few carbapenemases that hydrolyze carbapenem. The lower incidence of nephrotoxicity of meropenem (compared with imipenem) has been correlated with its greater stability to DHP-I. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

10 Imipenem / cilastatin vs Meropenem
Higher reported incidence of seizures. A 1g of imip./cilas require 200 ml saline to dissolve, whereas 1g of meropenem dissolves in only 20 ml saline. Meropenem can be given either by i.v bolus or i.v infusion Lower incidence of nephrotoxicity of meropenem (compared with imipenem) Imip./cilas should be given only by i.v infusion. Less suitable for fluid restricted pts Not suitable for outpatients- need hospitalization Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

11

12 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
MONOBACTAMS AZTREONAM Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

13 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
MONOBACTAMS Monobactams have a monocyclic β-lactam ring and are resistant to β-lactamases Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

14 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
AZTREONAM Mechanism of action Aztreonam was isolated from Chromobacterium violaceum. Similar to other B- lactams. Aztreonam is the first clinically useful monobactam. The antimicrobial activity of Aztreonam differs from those of other β-lactam antibiotics and more closely resembles that of an aminoglycosides in activity without the nephrotoxicity of aminoglycosides. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

15 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
AZTREONAM Antibacterial spectrum Active only against G- aerobic bacteria (pseudomonas, N. gonorrhea, N. meningitidis, H. influenzae and enterobacteriaceae ) Inactive against G+ and anaerobic bacteria. The combination of Aztreonam and piperacillin is synergistic against some strains of P. aeruginosa and Enterobacter spp. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

16 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
AZTREONAM Pharmacokinetics Poorly absorbed orally( i.v / 8 hr ) Limited penetration into the CSF Excreted primarily by the kidney Half- life 2 hr Side effects Similar to other B- lactams. Pts allergic to penicillins and cephalosporins can receive aztreonam Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

17 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
AZTREONAM Clinical uses of aztreonam Active against G- aerobes only Alternative for penicillins and cephalosporins. Safe alternative to aminoglycosides, esp. in elderly and pts with renal impairments. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

18 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
TIGEMONAM It is an investigational monobactam that is orally active. It is highly resistant to β-lactamases. The antibacterial spectrum of activity of tigemonam resembles that of aztreonam. It is very active against the Enterobacteriaceae, including: E. coli, Klebsiella, Proteus, Enterobacter species. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

19 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
QUINOLONES Norfloxacin Ciprofloxacin, Ofloxacin, Levofloxacin, Moxifloxacin Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

20 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
QUINOLONES Mechanism of action: Inhibit bacterial DNA synthesis by inhibiting DNA gyrase and topoisomerase IV resulting in rapid cell death. Mechanism of resistance: Chromosomal: Alter target enzymes: DNA gyrase and topoisomerase IV Decreased drug penetration: Pseudomonas, E. coli Plasmid: seen in some K. pneumoniae and E. coli Mutations in both target enzymes are needed to produce significant resistance. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

21 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
QUINOLONES Quinolones (1st generation) Highly protein bound Mostly used in UTIs Fluoroquinolones (2nd, 3rd and 4th generation) Modified 1st generation quinolones Not highly protein bound Wide distribution to urine and other tissues; limited CSF penetration. Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

22 QUINOLONES

23 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
QUINOLONES [Conc] > serum: Prostate tissue Stool Bile Lung Neutrophils Macrophages Kidneys [Conc] < serum: Prostatic tissue fluidBoneCSF Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

24 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
QUINOLONES Drug interactions: ↓ absorption: Al3+, Mg2+, and Ca2+ antacids CYP450 inhibition potential drug interactions for ciprofloxacin. Example: Can increase warfarin exposure (real changes in INR are rare, but monitor) Adverse effects: GI: Nausea, vomiting CNS: HA, dizziness, confusion, insomnia, delerium, hallucinations, seizure (rare) Cardiovascular: Torsades de pointes (rare) Musculoskeletal: Rupture of tendon (rare) Neurologic: Polyneuropathy (rare) Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

25 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
Ciprofloxacin Administration [Usual Dosage]: IV, PO [500 – 750 mg q 8-12h] Spectrum: Gram- aerobic rods, and Legionella, and other atypicals. Poor activity against Strep. pneumoniae. Indications: Nosocomial pneumonia Intra-abdominal infections Uncomplicated/complicated UTI Anthrax exposure and prophylaxis Unique Qualities: Binds divalent cations (i.e. Ca & Mg) which decreases absorption Increased effects of warfarin ADRs QTC prolongation, torsades de pointes, arrhythmias Nausea, GI upset Interstitial nephritis Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

26 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital
Levaquin Administration [Usual Dosage]: IV, PO and ophthalmic [ mg q24h] Spectrum: Gram-, Gram+ (S. aureus including MRSA & S. pneumoniae) and Legionella pneumophila, atypical resp. pathogens, Mycobacterium tuberculosis. Indications: Chronic bronchitis and Community acquired Pneumonia. Nosocomial pneumonia Skin & Soft Tissue infections Intra-abdominal infections Unique Qualities: Binds divalent cations (i.e. Ca & Mg) which decreases its absorption ADRs Blood glucose disturbances in DM patients QTC prolongation, torsades de pointes, arrhythmias Nausea, GI upset Interstitial nephritis Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

27 QUINOLONES

28 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital

Download ppt "Antibiotic Therapy in the Critically Ill Surgical and Trauma Patient - Monobactams Carbapenems, Quinolones Nir Hus MD., PhD. 01/12/2011."

Similar presentations

All the following are antibiotics used for gram –ve bacteria.

All the following are antibiotics used for gram –ve bacteria.
CARBAPENEMS e.g. Imipenem / Cilastatin Meropenem

CARBAPENEMS e.g. Imipenem / Cilastatin Meropenem
ANTIBACTERIAL ACTIVITY Wide spectrum of activity vs aerobic bacteria. Wide spectrum of activity vs aerobic bacteria. Newer 3 rd and 4 th generation.

ANTIBACTERIAL ACTIVITY Wide spectrum of activity vs aerobic bacteria. Wide spectrum of activity vs aerobic bacteria. Newer 3 rd and 4 th generation.
Fluoroquinolones Mark S. Johnson, Pharm.D., BCPS Associate Professor and Director of Postgraduate Education.

Fluoroquinolones Mark S. Johnson, Pharm.D., BCPS Associate Professor and Director of Postgraduate Education.
 Cefixime is quickly establishing in Western countries as a potent broad-spectrum antibiotic with a variety of indications. A multinational, nonrandomized.

 Cefixime is quickly establishing in Western countries as a potent broad-spectrum antibiotic with a variety of indications. A multinational, nonrandomized.
GLYCOPEPTIDES Vancomycin ; Teicoplanin Vancomycin Mechanism of action Inhibits cell wall synthesis Antibacterial activity Bactericidal against aerobic.

GLYCOPEPTIDES Vancomycin ; Teicoplanin Vancomycin Mechanism of action Inhibits cell wall synthesis Antibacterial activity Bactericidal against aerobic.
AMINOGLYCOSIDES Streptomycin* Gentamicin* Tobramycin* Amikacin Kanamycin Neomycin(topical) * most commonly used Antibacterial Spectrum Bactericidal ( exclusive.

AMINOGLYCOSIDES Streptomycin* Gentamicin* Tobramycin* Amikacin Kanamycin Neomycin(topical) * most commonly used Antibacterial Spectrum Bactericidal ( exclusive.
PHL 424 Antimicrobials 6 th Lecture By Abdelkader Ashour, Ph.D. Phone: 4677212

PHL 424 Antimicrobials 6 th Lecture By Abdelkader Ashour, Ph.D. Phone:
FLUOROQUINOLONES Ciprofloxacin Norfloxacin Ofloxacin Pefloxacin CIPROFLOXACIN Mechanism of action Inhibit DNA synthesis by inhibiting DNA gyrase.

FLUOROQUINOLONES Ciprofloxacin Norfloxacin Ofloxacin Pefloxacin CIPROFLOXACIN Mechanism of action Inhibit DNA synthesis by inhibiting DNA gyrase.
CEPHALOSPORINS First used clinically in the early 1960’s. First used clinically in the early 1960’s. They have an important role in the modern treatment.

CEPHALOSPORINS First used clinically in the early 1960’s. First used clinically in the early 1960’s. They have an important role in the modern treatment.
Cephalosporins.

Cephalosporins.
Beta-lactam antibiotics - Cephalosporins

Beta-lactam antibiotics - Cephalosporins
Students should  Specify microorganisms causing meningitis  Delineate the therapeutic strategy  Classify the relevant antibiotics used  Expand on.

Students should  Specify microorganisms causing meningitis  Delineate the therapeutic strategy  Classify the relevant antibiotics used  Expand on.
Non-pharmacologic Elevate the affected area to facilitate gravity drainage of edema and inflammatory substances – Patients with edema may benefit from.

Non-pharmacologic Elevate the affected area to facilitate gravity drainage of edema and inflammatory substances – Patients with edema may benefit from.
Antibacterial Inhibitors of Cell Wall Synthesis –Very high therapeutic index Low toxicity with high effectiveness β- lactam Drugs –Inhibit peptidoglycan.

Antibacterial Inhibitors of Cell Wall Synthesis –Very high therapeutic index Low toxicity with high effectiveness β- lactam Drugs –Inhibit peptidoglycan.
Beta lactam antibiotics & Other cell wall synthesis inhibitors

Beta lactam antibiotics & Other cell wall synthesis inhibitors
Sulfonamides, trimethoprim and Quinolones

Sulfonamides, trimethoprim and Quinolones
CELL WALL SYNTHESIS INHIBITORS

CELL WALL SYNTHESIS INHIBITORS
Cephalosporins First Generation Cephalosporins

Cephalosporins First Generation Cephalosporins
AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.

AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.

Similar presentations

Ads by Google